Study on infections in severe liver failure
Part of Digestive system clinical trials.
This study looks at what types of infections happen in people with severe hepatitis (liver failure). It aims to help doctors better understand and treat these infections. You may qualify if you have a long-term hepatitis B or recent hepatitis E infection and your liver function has gotten much worse quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have had hepatitis B for more than 6 months, or have a current hepatitis E infection.
- Your jaundice (yellowing of skin/eyes) has gotten much worse in a short time, confirmed by blood tests.
- You have a significant bleeding risk (low blood clotting factor) not caused by other medical issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a study that collects real-world information about people with liver failure or “pre-liver failure.” It aims to help doctors choose the best management approach for patients like you and improve care over time.
This trial studies fecal microbiota transplantation (a transfer of healthy gut bacteria from a donor) to help people with worsening liver failure. It may help by changing gut bacteria, which can affect complications like confusion, fluid buildup, infections, and kidney problems.
This study looks at infections in people with cirrhosis caused by hepatitis B or C. It aims to find which germs cause these infections, so doctors can choose better treatments.
This study follows people with chronic liver disease who develop a serious infection called sepsis. The goal is to learn more about how to better treat or manage this condition.
This study looks at long-term survival in people ages 18–65 who are hospitalized with hepatitis B–related acute-on-chronic liver failure. It may help doctors better predict prognosis and improve care for people with this serious condition.
This study analyzes gene activity in patients with severe liver failure or sepsis to understand why some recover and others don't. It may lead to better treatments in the future.
Hear when a new Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.